ericvivier.bsky.social
@ericvivier.bsky.social
Incredible party at the International Congress of Immunology in Vienna.
It was such a thrill to play. We are ‘The Engagers’: Jim Allison, Luke O’Neil, Matteo Iannacone, Shalin Naik, Barbara Bohle, Jaime Torque.
Let’s do it again asap 🎶🎸
August 23, 2025 at 5:21 AM
Reposted
We recorded today at #IUIS2025!

We had a great time chatting with Dr. ‪@ericvivier.bsky.social from @univ-amu.fr about the importance of funding science. Stay tuned for the episode coming out September 9th!
August 19, 2025 at 9:53 PM
Reposted
Preprint: Integrated Single Cell Analysis Identifies CD39+ Tumor-Associated NK Cells with Cytotoxic Potential in Lung Cancer @ericvivier.bsky.social et al
papers.ssrn.com/sol3/papers....
July 19, 2025 at 8:48 PM
Reposted
Innate lymphoid cells originate from fetal liver–derived tissue-resident progenitors | Science Immunology www.science.org/doi/10.1126/...
Innate lymphoid cells originate from fetal liver–derived tissue-resident progenitors
Fetal liver–derived ILC progenitors seed peripheral tissues and generate local ILCs independently of the bone marrow throughout life.
www.science.org
July 15, 2025 at 1:16 AM
Not all lymphocytes come from the bone marrow: revisiting extramedullar lymphopoiesis
www.science.org/doi/10.1126/...
Innate lymphoid cells originate from fetal liver–derived tissue-resident progenitors
Fetal liver–derived ILC progenitors seed peripheral tissues and generate local ILCs independently of the bone marrow throughout life.
www.science.org
July 11, 2025 at 6:15 PM
Reposted
In Science, researchers present a new method to safely and preferentially generate CAR T cells directly inside the body using targeted lipid nanoparticles that deliver mRNA directly to T cells.

Learn more: scim.ag/4jVfcuk
#SciencePerspective: scim.ag/3STvdWC
June 19, 2025 at 7:56 PM
Happy to share this update on Natural killer cells in cancer therapies: hstalks.com/t/5982/harne...
Harnessing NK cells in cancer therapies
Click to launch & play an online audio visual presentation by Prof. Eric Vivier on Harnessing NK cells in cancer therapies, part of a collection of multimedia lectures.
hstalks.com
June 4, 2025 at 1:58 PM
Merci à Paul Molga et au journal ´Les Echos’ pour l’intérêt porté à nos recherches en immunothérapie www.lesechos.fr/idees-debats...
www.lesechos.fr
May 17, 2025 at 1:40 PM
Reposted
Félicitations au Pr. @ericvivier.bsky.social, du Centre d’Immunologie de Marseille-Luminy, lauréat du Prix ARC Léopold Griffuel ! Une belle reconnaissance pour ses avancées majeures en immunothérapie 🔬👏

#Recherche #Immunologie #AMU #ExcellenceScientifique
April 17, 2025 at 12:06 PM
The PSCC is now fully operational at Campus Grand Parc! Join us at the Europe’s premier hub for accelerating cancer innovation. This is the place to be.
- State-of-the-art offices and labs
- Cutting-edge technology platforms
Metro 14 – Villejuif Gustave Roussy
March 27, 2025 at 10:38 AM
With Gustave Roussy and all the stakeholders of the Campus Grand Parc, the Paris Saclay Cancer Cluster (PSCC) is building a new city dedicated to the fight against cancer.
March 18, 2025 at 8:52 AM
Ravi de discuter des progrès en immunothérapie des cancers sur France Inter le lundi 3/2/25, la veille de la journée mondiale contre le cancer
January 30, 2025 at 4:35 PM
Reposted
1/ 📢 Register for the 2025 Henry Kunkel Society Meeting on "Genes & Immunity" and join us in Belgrade from April 10-12, 2025. www.henrykunkelsociety.org/meetings/
#HKS2025 #Immunology 🧬🔬
Meetings – Henry Kunkel Society
www.henrykunkelsociety.org
January 24, 2025 at 4:42 PM
www.linkedin.com/posts/ice360...

Many thanks for the invitation to share our data on the harnessing of NK cells in clinics.
@Innate Pharma, @CIML, @Aix-Marseille Université (AMU), @Paris Saclay Cancer Cluster (PSCC), @APHM (Assistance Publique - Hopitaux de Marseille), @Gustave Roussy
Cell Therapy Innovation 360° on LinkedIn: #immunologie #nkcells #oncologie #thérapiecellulaire #cellengager #ice360
🔬 ICE360 : Plongez dans l'univers des cellules NK avec Eric Vivier   Nous sommes ravis d'annoncer la participation d'Eric Vivier, expert internationalement…
www.linkedin.com
January 24, 2025 at 3:40 PM